Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panelUrsula Creutzig, Dirk Reinhardt, Marry M. van den Heuvel‐Eibrink et al.|Blood|2012Cited by 575
Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non‐Down syndromeYusuke Hara, Yasuhide Hayashi, Norio Shiba et al.|Genes Chromosomes and Cancer|2017Cited by 72
Clinical characteristics and outcome of refractory/relapsed myeloid leukemia in children with Down syndromeTakashi Taga, Souichi Adachi, Akiko Saito et al.|Blood|2012Cited by 62
Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy for Myeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in JapanTakashi Taga, Souichi Adachi, Tomoyuki Watanabe et al.|Pediatric Blood & Cancer|2015Cited by 48
EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemiaH. Matsuo, Souichi Adachi, Mikio Kajihara et al.|Haematologica|2014Cited by 42